PROPRANOLOL News

PROPRANOLOL currently has 8 news articles, with 34 predicted indications.

This page combines the AI-predicted indications for PROPRANOLOL with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (34):
- verrucous hemangioma (99.0%)
- spindle cell hemangioma (99.0%)
- lymphangioma (99.0%)
- cavernous hemangiomas of face-supraumbilical midline raphe syndrome (99.0%)
- multifocal atrial tachycardia (disease) (99.0%)
- glomus tumor (99.0%)
- familial hypertrophic cardiomyopathy (99.0%)
- hypertension (99.0%)
- His bundle tachycardia (99.0%)
- congenital hemangioma (99.0%)
- primary intralymphatic angioendothelioma (99.0%)
- placental hemangioma (99.0%)
- atrial fibrillation (disease) (99.0%)
- hypertensive disorder (99.0%)
- primary intraosseous venous malformation (99.0%)
- laryngotracheal angioma (99.0%)
- cavernous hemangioma (99.0%)
- retinal capillary malformation (99.0%)
- pulmonary venoocclusive disease (99.0%)
- epithelioid hemangioendothelioma (99.0%)
- kaposiform hemangioendothelioma (99.0%)
- composite hemangioendothelioma (99.0%)
- hemangioma (99.0%)
- Kasabach-Merritt syndrome (99.0%)
- tufted angioma (disease) (99.0%)
- hypertrophic cardiomyopathy (99.0%)
- retiform hemangioendothelioma (99.0%)
- hereditary neurocutaneous angioma (99.0%)
- distal myopathy, Tateyama type (99.4%)
- congenital myopathy with excess of thin filaments (99.3%)
- hypertrophic cardiomyopathy due to intensive athletic training (99.2%)
- chondroma (99.1%)
- cirrhotic cardiomyopathy (99.1%)
- cardiomyopathy (99.1%)